Prelude Capital Management, LLC Abiomed Inc Transaction History

Prelude Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $443,756 - $551,671	-1,830 Reduced 64.37%	1,013 $249,000
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $580,028 - $874,029	2,581 Added 985.11%	2,843 $704,000
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $37,046 - $67,357	262 New	262 $63,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $73,738 - $110,745	-565 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $90,010 - $126,300	565 New	565 $96,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $39,149 - $44,450	-156 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $105,304 - $138,017	-381 Reduced 70.95%	156 $45,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $150,939 - $238,562	537 New	537 $175,000
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $13,472 - $17,090	-38 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $103,998 - $166,882	-374 Reduced 90.78%	38 $16,000
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $40,230 - $61,832	-209 Reduced 33.66%	412 $120,000
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $2,700 - $3,195	16 Added 2.64%	621 $116,000
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $87,960 - $102,003	605	605 $102,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.